Big Pharma has a Super Bowl ad dilemmastar-news.press/wp

Big Pharma is often converted to NFL games to bother their blockbuster treatment, but drug manufacturers usually hesitated to advertise during the Great Game. This hesitation could mean that pharmaceutical companies lack high opportunities to connect to viewers, according to the new analysis by the TV outcomes Edo.

New Nordisk (NGO-0.62%It has broadcast a total of 16 advertisements for their weight loss medications and drug weight loss drugs and Wegovy during Games in the regular season 2024-2045 NFL, which results in almost 283 million impressions, according to EDO data. Pfizer (Pfe-1.58%) Running 10 ads for its Covid-19 treatment Paxlovid, generating over 147 million impressions.

Given these numbers, you would think that drug ad companies would jump on air ads about what is usually the most viewed broadcasting in America. However, there are several reasons for drugs that are drug ads reluctant to air ads during the Super Bowl.

In addition to the cost – 30-second during Super Vessel during Super $ 8 millionViewers usually expect advertisements during a party game and light. This can be a difficult balance for a prescription on land for land when needed to list all potential side effects.

Edo Chief of Client Solutions Laura Grover said that the great price of advertisements is also not valid for medication treated with low case rate – measurement of new cases of diseases over time.

“Super Bowl is a great tool that has reached a lot of people at the same time and pay the premium for it,” Grover said. “So if you’re focused on a medicine that has a very small incidence rate, it may not be the best investment.”

Super Bowl Ads can also raise an overview of Big Pharma. In 2016. AstraZeneca year (Azn-0.58%) And Daiichi Sankyo bought a prominent advertising space for the drug market for the treatment of closed prison. The White house and at least two police chiefs respondedSaying that companies should have warned viewers about opioidal addiction instead of prison. Between 1999-2019, the CDC recorded half a million deaths associated with opioid overiques in the United States.

For the manufacturers of drugs trying to cash in the Super container, Prime ad place can have a great payout, especially when it comes to the engagement of the spectators with the brand. “Super vessel is a different kind of view,” Grover said. “People are taught for ads as much as play.”

Only two drug companies broadcast ads during last year’s Super Bowl Festivities: Pfizer and Stelllaswhich broadcast an ad during the show before the game.

Pfizer broadcast a 60-second that promoted the company scientific heritage. According to Edo, that the ad resulted in a greater engagement, compared to the Median Super Bowl ad between 2020. and 2024. years. Edo is measured by analyzing measurement activities and visits to the website after ads.

“Because we focus on the Live Line TV, we know exactly when the ads are broadcast. – – As a real second when it was broadcast,” Grover explained. “And then we tie it up to search the data that are also at the level of another.”

For this year’s super bowl, at least two drug companies have already announced plans for commercials during the game.

Tilenian Targetical Teletectical Company Targeting (Him+ 8,67%) is placed on the air First-ever super commercial vessel Advertising of its minor costs for weight loss – including the version of Wegovy outside the brand.

Novartis (Nvs-0.12%) It also emits the first super bowls for great. Their ads contains an actress Hailee Steinfeld And aims to raise awareness of breast cancer and the importance of cancer projections.

“If you have a real medicine that has a wider appeal, these live events, the NFL and Super Bowl can be really strong environments for pussy pharmacics,” Grover said.